Merck Combination Wins EU Panel Backing for Advanced Kidney Cancer
An EU panel backed Merck’s Welireg-lenvatinib combination for advanced kidney cancer.
Related stories
AstraZeneca Hypertension Drug Recommended for EU Approval
The European Medicines Agency's human-medicines committee recommended AstraZeneca's Baxfendy for approval to treat insufficiently controlled hypertension.
L impact | REGULATION | Nov 13, 2026, 11:47 AM UTC
CHMP Recommends EU Approval of Roche’s Gazyva for Lupus
The European Medicines Agency’s CHMP recommended EU approval of Roche’s Gazyva/Gazyvaro for systemic lupus erythematosus (SLE).
M impact | REGULATION | Nov 13, 2026, 11:30 AM UTC
Irish regulator fines Tinder owner €11 million
Ireland's data protection regulator fined the owner of Tinder €11 million.
M impact | REGULATION | Nov 13, 2026, 11:27 AM UTC
EMA Committee Recommends Indication Extensions for Bexsero and Talzenna
The EMA's CHMP recommended extensions of indication for Bexsero and Talzenna.
M impact | REGULATION | Nov 13, 2026, 11:16 AM UTC
EMA Committee Recommends Steglatro Indication Extension
The EMA’s CHMP recommends extending Steglatro’s therapeutic indication.
L impact | REGULATION | Nov 13, 2026, 11:07 AM UTC
Megaspeed Unit Under Probe in Malaysia Over AI Chip Re-exports
M impact | REGULATION | Nov 13, 2026, 11:02 AM UTC